Defibrination with ancrod (arvin) in peripheral arterial occlusive diseases. Principle, indications, contraindications technic and course
Heidrich, H.
Zfa. Zeitschrift für Allgemeinmedizin 54(32): 1648-1651
1978
ISSN/ISBN: 1433-6251 PMID: 735320 Document Number: 134937
Document emailed within 1 workday
Related Documents
Böhme, H. 1978: Defibrination in the therapy of arterial occlusive diseases ZFA. Zeitschrift für Allgemeinmedizin 54(32): 1644-1647Thomson, N.C.; Hutcheon, A.W.; Dagg, J.H. 1976: Acquired resistance to prolonged treatment with intravenous "Arvin" (ancrod) British Journal of Clinical Practice 30(11-12): 232-233
Bollinger, A. 1987: Secondary prevention of peripheral arterial occlusive diseases Therapeutische Umschau. Revue Therapeutique 44(9): 682-685
Altmann, E.; Schmidt, P.K. 1987: Expert assessment of peripheral arterial occlusive diseases Zeitschrift für Arztliche Fortbildung 81(17): 911-913
Alexander, K. 1993: Conservative therapy of peripheral arterial occlusive diseases Zeitschrift für Kardiologie 82(Suppl): 89-98
Moucka, J.; Jäger, K. 1990: Rational approach to peripheral arterial occlusive diseases Schweizerische Rundschau für Medizin Praxis 79(50): 1553-1559
Inoue, Y. 2016: Open surgical treatment for peripheral arterial occlusive diseases Nihon Rinsho. Japanese Journal of Clinical Medicine 74(Suppl 2): 337-342
Loew, D.; Hess, H. 1982: Aggregation inhibitors or anticoagulants in the prevention of peripheral arterial occlusive diseases Die Medizinische Welt 33(43): 1511-1515
Naish, P.F.; Evans, D.J.; Peters, D.K. 1975: The effects of defibrination with ancrod in experimental allergic glomerular injury Clinical and Experimental Immunology 20(2): 303-309
Hubl, S.; Wesolowski, J. 1973: Intra-arterial administration of penicillin and vasodilating agents in occlusive diseases of the peripheral arteries Polski Tygodnik Lekarski 28(30): 1150-1151
Lebrun, T.; Selke, B.; Sailly, J.C.; Boissier, C.; Mosnier, M. 1994: The introduction of economic criteria into the management of arterial disease: an illustration with regard to the socioeconomic consequences of peripheral occlusive arterial disease of the lower limbs Journal of Cardiovascular Pharmacology 23(Suppl 3): S17-S21
Kröger, K. 2005: Peripheral arterial occlusive disease--the forgotten arteriosclerosis MMW Fortschritte der Medizin 147(18): 21
Kiesewetter, H.; Jung, F. 1984: Hemorheologic therapy in peripheral arterial occlusive disease Fortschritte der Medizin 102(37): 921-924
Sailer, S.; Pilger, E. 1985: Fibrinolytic therapy of peripheral arterial occlusive disease Wiener Medizinische Wochenschrift 135(15-16): 393-399
Périard, D.; Hayoz, D.; Mazzolai, L. 2009: Medical therapy in peripheral arterial occlusive disease Revue Medicale Suisse 5(189): 312-315
Spittell, J.A. 1992: Conservative management of occlusive peripheral arterial disease Cardiovascular Clinics 22(3): 209-215
Cole, C.W.; Hill, G.B.; Farzad, E.; Bouchard, A.; Moher, D.; Rody, K.; Shea, B. 1993: Cigarette smoking and peripheral arterial occlusive disease Surgery 114(4): 753
Ratnatunga, C. 1998: Chronic peripheral occlusive arterial disease in Sri Lanka Ceylon Medical Journal 43(4): 182-184
Kiesewetter, H.; Jung, F.; Erdlenbruch, W.; Wenzel, E. 1992: Haemodilution in patients with peripheral arterial occlusive disease International Angiology: a Journal of the International Union of Angiology 11(3): 169-175
Spittell, J.A. 1982: Diagnosis and treatment of occlusive peripheral arterial disease Geriatrics 37(1): 57-67